FRES: Prakiraan rega marang bathi fresh2.co

FRES (fresh2.co) - tandha merek perusahaan

The forward P/E for the next year of Fresh2 Group Limited (FRES) is reacting to price volatility and logistical risks within the fresh produce segment, with the 0.00 mark reflecting the latest data. Scalability is driven by a warehouse-less B2B model, while the digitalization of supply chains via AI solutions expands the distributor pool. This chart's price action allows for an assessment of the market consensus regarding capitalization payback through expected earnings.

Kapitalisasi marang proyeksi bathi: Fresh2 Group Limited (FRES) kanggo 21.02.2024 - 04.01.2025

Rincian analitis lan laporan data perusahaan Fresh2 (FRES)

- nilai saham lan prakiraan konsensus rega:
Pambiji fundamental perusahaan:FRES Fresh2 Group
Produk mawa merek Fresh2

By developing a digital B2B platform to optimize food logistics, Fresh2 Group Limited is laying the foundation for scalability through the automation of small business procurement. The company's forward P/E valuation correlates current market value with expected earnings, allowing investors to determine whether the premium for technological growth is justified by actual expansion rates and the cost of capital.

Pesaing langsung

Rega marang bathi mangsa ngarep Agilent (A)|Rega marang bathi mangsa ngarep DGX (Quest Diagnostics Inc.)|Illumina Corp - Prakiraan rega marang bathi|Exact Sciences Inc. (EXAS) - Rasio prakiraan rega marang bathi|RVTY - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi bio-rad.com BIO|NNNN: Pangali Forward P/E|SHC - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep QuidelOrtho Corp|OPKO Health Corp. (OPK) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E CDNA|MRVI: Rasio rega marang bathi sing dikarepake|Rega marang bathi mangsa ngarep Fulgent Genetics FLGT|Pangali mangsa ngarep rega marang bathi LAB|Cytek Bio - Pangali Forward P/E|Rasio prakiraan rega marang bathi OraSure Corp|exagen.com (XGN) - Rega marang bathi mangsa ngarep|MDXH - Kapitalisasi marang proyeksi bathi|LUCD (Lucid Diagnostics) - Pangali Forward P/E|PRE: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Insight Molecular Diagnostics (IMDX)|Prakiraan rega marang bathi trinitybiotech.com TRIB|Pangali mangsa ngarep rega marang bathi ProPhase Labs, Inc.|Pangali Forward P/E ainos.com AIMD|Pangali forward rega marang bathi CODX|HSCS: Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi Biomerica, Inc BMRA|CDIO (Cardio Diagnostics Holdings) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi ONCO (Onconetix, Inc.)|Prakiraan rega marang bathi viraxbiolabs.com (VRAX)|Pangali Forward P/E BJDX|Rega marang bathi mangsa ngarep AWH (Aspira Women's Health, Inc.)|Accelerate Diagnostics, Inc (AXDX) - Rasio rega marang bathi sing dikarepake|CNTG - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi Enzo (ENZ)|GENE: Rega marang bathi mangsa ngarep|23andMe (ME) - Rega marang bathi mangsa ngarep|Psychemedics Corp. (PMD) - Pangali Forward P/E